Latest News and Press Releases

EVIA OYJ PÖRSSITIEDOTE 17.1.2008, KLO 11.00 Evia Oyj:n vuosikooste 2007 Vuosikoosteeseen on listattu Evia Oyj:n vuoden 2007 aikana...

Indre værdi for Alm. Brand Formue A/S ...

PROGRESS IN EPROTIROME (KB2115) DEVELOPMENT  Eprotirome approved as generic name for KB2115  The continued clinical development of eprotirome is progressing according to plan. All patients in a new...

FRAMSTEG I UTVECKLINGEN AV EPROTIROME (KB2115)  Eprotirome har godkänts som generiskt namn för KB2115  Den fortsatta kliniska utvecklingen av eprotirome går framåt enligt plan. Alla patienter i en...

Spar Nord FormueInvest A/S, Indre Værdi er den 17. januar 2008 beregnet til kr. 90,50 ...

The acceptance period for the Public Offer for shares in Stork N.V. by London Acquisition B.V. ended on 14th of January 2008 with shareholders representing 98% of outstanding share capital of Stork...

Teknisten ongelmien vuoksi Nordea Pankki Suomi Oyj ei pysty pitämään markkinatakausnoteerauksia Eurostoxx50 warranteissa. Normaaliin markkinatakaukseen pyritään palaamaan mahdollisimman pian. Nordea...

Odfjell SE`s fourth quarter 2007 result will be released on Tuesday 5 February 2007. The result will be published on Oslo Børs at www.newsweb.no  as well as made available on www.huginonline.com...

Odfjell SE`s fourth quarter 2007 result will be released on Tuesday 5 February 2007. The result will be published on Oslo Børs at www.newsweb.no  as well as made available on www.huginonline.com...

The new production unit for Finale dosage forms will be ready in the end of 2008. Its planned production capacity will be 2 billion tablets and capsules per year. The prospective production unit...